C

Cel-Sci Corp

CVM

1.15000
USD
0.02
(1.77%)
Market Closed
Volume
39,254
EPS
0
Div Yield
0
P/E
-2
Market Cap
56,217,110
Related Instruments
A
AYTU
-0.05000
(-1.89%)
2.60000 USD
I
INO
-0.670
(-6.28%)
10.000 USD
N
NVCN
0
(0%)
0.000000 USD
T
TNXP
0.00960
(1.92%)
0.51050 USD
News

Title: Cel/Sci Corp

Sector: Healthcare
Industry: Biotechnology
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.